ftInvstr
TBOTEK · Consumer Cyclical ₹1679.0 -2.72% Mkt Cap ₹17892 Cr

TBOTEK

Consumer Cyclical Travel Services
₹1679.0
-2.72% today · 30d +3.95%
as of 2026-09-04
Price · Daily Candles
“TBOTEK's Q4 revenue soars 85%, profit growth lags, as FIIs reduce stake.”
TBOTEK reported significant revenue growth of 85.78% year-over-year to ₹784.0 Cr in Q4 2025, but net profit growth was a more modest 7.44% to ₹54.0 Cr for the same period. The company's 3-year net profit CAGR stands at an impressive 89.62%, indicating strong historical expansion. However, the stock has experienced recent price pressure, with a 6-month return of -24.39% and a current price -31.01% off its 52-week high.
BULL CASE
+Q4 2025 revenue surged 85.78% YoY to ₹784.0 Cr, reflecting strong top-line performance.
+Annual revenue witnessed a 3-year CAGR of 49.52% and net profit a 3-year CAGR of 89.62% as of March 2025, showcasing robust historical growth.
+Operating profit for Q4 2025 increased by 56.85% YoY to ₹113.0 Cr.
+The company's ROCE is healthy at 27.0%, compared to sector peers like IXIGO (14.59%) and YATRA (9.26%).
BEAR CASE
Net profit growth in Q4 2025 was a lower 7.44% YoY, despite strong revenue gains.
The stock is trading 31.01% below its 52-week high of ₹1764.8, and has seen a 6-month return of -24.39%.
Operating profit margin (OPM) saw a -2.23% change YoY in Q4 2025, indicating some margin compression.
FIIs decreased their stake by -1.14% in Q1 2026, while DIIs increased theirs by 1.33%.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹926 Cr
+81.07% YoY
NET PROFIT
₹83 Cr
+32.38% YoY
OPM
16.08%
-0.49pp YoY
EPS
₹7.77
PE 53.76
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-26.2%, h2=-38.2%, h3=-31.8% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
TBOTEK's PE of 53.76 and ROCE of 27.0% price it higher than peers like IRCTC (PE 32.68, ROCE 45.71%) but with stronger profitability than IXIGO (ROCE 14.59%).
PEERPEROCE %
TBOTEK53.7627.0
IRCTC32.6845.71
IXIGO14.59
THOMASCOOK20.0319.73
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
64
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 90
Valuation STRETCHED 20
Growth STEADY 67
Profitability HIGH 85
Technicals STRONG 70
Risk MODERATE 50
Key Stats
TTM PE
53.76
P/B
9.37
52W HIGH
₹1764.8
OFF HIGH
-4.86%
MKT CAP
₹17892 Cr
◉ Active Signals
MACDNeutral-7.2373
RSI(14)Neutral53.78
Near 52W HighBullish-4.86
Street Consensus
10 analysts
₹1719.2
mean target
Low ₹1360.0Now ₹1679.0High ₹2000.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold TBOTEK and at what entry.

Sign up freeSign in